Phase Ib/II trial of lenvatinib plus pembrolizumab in advanced melanoma.

被引：2
作者：
Taylor, Matthew H.
Vogelzang, Nicholas J.
Cohn, Allen Lee
Stepan, Daniel E.
Shumaker, Robert Charles
Dutcus, Corina E.
Guo, Matthew
Schmidt, Emmett V.
Rasco, Drew W.
机构：
[1] Oregon Hlth & Sci Univ, Portland, OR 97201 USA
[2] Comprehens Canc Ctr Nevada, Las Vegas, NV USA
[3] US Oncol, Rocky Mt Canc Ctr, Denver, CO USA
[4] Eisai Inc, Woodcliff Lake, NJ USA
[5] Merck & Co Inc, Kenilworth, NJ USA
[6] South Texas Accelerated Res Therapeut, San Antonio, TX USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2019年 / 37卷 / 08期
关键词：
D O I：
10.1200/JCO.2019.37.8_suppl.15
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
15
引用
收藏
页数：2
相关论文
共 50 条
[31]   Lenvatinib plus pembrolizumab versus lenvatinib plus placebo for advanced hepatocellular carcinoma (LEAP-002) a randomised, double-blind, phase 3 trial [J].
Llovet, Josep M. ;
Kudo, Masatoshi ;
Merle, Philippe ;
Meyer, Tim ;
Qin, Shukui ;
Ikeda, Masafumi ;
Xu, Ruocai ;
Edeline, Julien ;
Ryoo, Baek-Yeol ;
Ren, Zhenggang ;
Masi, Gianluca ;
Kwiatkowski, Mariusz ;
Lim, Ho Yeong ;
Kim, Jee Hyun ;
Breder, Valeriy ;
Kumada, Hiromitsu ;
Cheng, Ann-Lii ;
Galle, Peter R. ;
Kaneko, Shuichi ;
Wang, Anran ;
Mody, Kalgi ;
Dutcus, Corina ;
Dubrovsky, Leonid ;
Siegel, Abby B. ;
Finn, Richard S. .
LANCET ONCOLOGY, 2023, 24 (12) :1399-1410
[32]   NEOplus: A phase II study of neoadjuvant lenvatinib and pembrolizumab in resectable mucosal melanoma [J].
Mao, L. ;
Bai, X. ;
Wei, X. ;
Dai, J. ;
Cui, C-L. ;
Chi, Z. ;
Sheng, X. ;
Lian, B. ;
Wang, X. ;
Bixia, T. ;
Si, L. ;
Guo, J. .
ANNALS OF ONCOLOGY, 2022, 33 (07) :S951-S951
[33]   A clinical and translational phase II trial of sequential axitinib and carboplatin/paclitaxel in advanced melanoma. [J].
Algazi, Alain Patrick ;
Cha, Edward ;
Pampaloni, Miguel H. ;
Behr, Spencer ;
Cortez, Brandon ;
Quiroz, Anteo ;
Coakley, Fergus V. ;
Liu, Songling ;
Daud, Adil .
JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
[34]   Lenvatinib Plus Pembrolizumab in Patients With Advanced Endometrial Cancer [J].
Makker, Vicky ;
Taylor, Matthew H. ;
Aghajanian, Carol ;
Oaknin, Ana ;
Mier, James ;
Cohn, Allen L. ;
Romeo, Margarita ;
Bratos, Raquel ;
Brose, Marcia S. ;
DiSimone, Christopher ;
Messing, Mark ;
Stepan, Daniel E. ;
Dutcus, Corina E. ;
Wu, Jane ;
Schmidt, Emmett V. ;
Orlowski, Robert ;
Sachdev, Pallavi ;
Shumaker, Robert ;
Casado Herraez, Antonio .
JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (26) :2981-2992
[35]   Pembrolizumab Plus Lenvatinib Approved in Advanced Endometrial Carcinoma [J].
Schuyler, Devon .
CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY, 2019, 17 (11) :610-610
[36]   Results of a phase II trial with cystemustine in advanced malignant melanoma. A trial of the EORTC clinical screening group [J].
Urosevic, V ;
Chollet, P ;
Adenis, A ;
Chauvergne, J ;
Fargeot, P ;
Roche, H ;
Kerbrat, P ;
Lentz, MA ;
Fumoleau, P ;
Chevallier, B .
EUROPEAN JOURNAL OF CANCER, 1996, 32A (01) :181-182
[37]   Clinical characteristics predictive of response to pembrolizumab in advanced melanoma. [J].
Tsai, Katy K. ;
Loo, Kimberly ;
Khurana, Neharika ;
Algazi, Alain Patrick ;
Hwang, Jimmy ;
Sanchez, Roberto ;
Krummel, Matthew ;
Rosenblum, Michael ;
Tumeh, Paul ;
Daud, Adil .
JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
[38]   A phase Ib study of pembrolizumab plus chemotherapy in patients with advanced cancer (PembroPlus) [J].
Weiss, Glen J. ;
Waypa, Jordan ;
Blaydorn, Lisa ;
Coats, Jessica ;
McGahey, Kayla ;
Sangal, Ashish ;
Niu, Jiaxin ;
Lynch, Cynthia A. ;
Farley, John H. ;
Khemka, Vivek .
BRITISH JOURNAL OF CANCER, 2017, 117 (01) :33-40
[39]   KEYNOTE-029: Efficacy and safety of pembrolizumab (pembro) plus ipilimumab (ipi) for advanced melanoma. [J].
Carlino, Matteo S. ;
Atkinson, Victoria ;
Cebon, Jonathan S. ;
Jameson, Michael B. ;
Fitzharris, Bernie M. ;
McNeil, Catriona M. ;
Hill, Andrew G. ;
Ribas, Antoni ;
Atkins, Michael B. ;
Thompson, John A. ;
Hwu, Wen-Jen ;
Hodi, F. Stephen ;
Menzies, Alexander M. ;
Guminski, Alexander David ;
Kefford, Richard ;
Shu, Xinxin ;
Ibrahim, Nageatte ;
Moreno, Blanca Hornet ;
Long, Georgina V. .
JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
[40]   A phase Ib study of pembrolizumab plus chemotherapy in patients with advanced cancer (PembroPlus) [J].
Glen J Weiss ;
Jordan Waypa ;
Lisa Blaydorn ;
Jessica Coats ;
Kayla McGahey ;
Ashish Sangal ;
Jiaxin Niu ;
Cynthia A Lynch ;
John H Farley ;
Vivek Khemka .
British Journal of Cancer, 2017, 117 :33-40
12345